Lymphoma
1 competing product in clinical development for Lymphoma.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tomivosertib (eFT-508) | eFFECTOR Therapeutics | Phase 1/2 | Terminated | 33 |
1 competing product in clinical development for Lymphoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Tomivosertib (eFT-508) | eFFECTOR Therapeutics | Phase 1/2 | Terminated | 33 |